Navigation Links
Mindray Medical to Exhibit at RSNA 2008 in Chicago, from November 30th to December 4th, 2008
Date:11/19/2008

SHENZHEN, China, Nov. 19 /PRNewswire-FirstCall/ -- Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, today announced that it will attend the 2008 Radiological Society of North America (RSNA) Conference in Chicago, Illinois at the McCormick Place from November 30th to December 4th, 2008.

Attending the conference from Mindray will be Mr. Ronald Ede, Group Vice President of International Operations, Mr. David Gibson, President of Mindray DS USA, Inc., Mr. Frank Gregorio, Vice President of Sales and Mr. Lee Weng, Vice President of Mindray Medical International Limited. Mindray will be occupying Booth 6459 Hall A.

    Mindray will exhibit the following products at the RSNA Conference:

    -- M5 Portable Color Ultrasound System
    -- DC-3 Color Ultrasound System
    -- DC-6 Color Ultrasound System
    -- DP-9900 Digital B/W Ultrasonic Diagnostic Imaging System
    -- DP-8800 Digital B/W Ultrasonic Diagnostic Imaging System
    -- DP-3300 Digital B/W Ultrasonic Diagnostic Imaging System
    -- DP-2200 Digital B/W Ultrasonic Diagnostic Imaging System
    -- DP-6600 VET Digital B/W Diagnostic Imaging System

Our expanded portfolio includes both the M5 and DC-3 which were introduced in the US in 2008. The M5 is the company's first laptop-size ultrasound imaging device, weighing only six kilograms and combining brilliant color imaging with uncompromised 2D performance. Hand Carried Ultrasound ("HCU") is one of the fastest growing ultrasound segments in the United States and in international markets. The M5 is ideally suited for doctors' offices, clinics and surgery centers that traditionally forego ultrasound imaging equipment due to space and applicable technology constraints.

The DC-3 color ultrasound imaging system is designed to have extensive applications in abdominal, OB/GYN, endovaginal, cardiac, small parts and pediatric markets. The product is ideally suited for U.S. hospitals, doctors' offices and veterinary clinics seeking to replace black and white ultrasound imaging systems. The DC-3 complements the company's FDA-approved DC-6 and portable M5 ultrasound imaging systems. For additional information about Mindray's Medical Imaging Systems product line, please go to http://www.mindray.com/main/products/index.jsp .

About Mindray

Mindray is a leading developer, manufacturer and marketer of medical devices worldwide. Established in 1991, Mindray offers a broad range of products across three primary business segments: patient monitoring & life support products, in-vitro diagnostic products and medical imaging systems. Mindray is globally headquartered in Shenzhen, China, with U.S. headquarters in Mahwah, New Jersey. Mindray also has another 12 international sales and service offices in Amsterdam, Frankfurt, Istanbul, London, Mexico City, Moscow, Mumbai, Paris, Sao Paolo, Seattle, Toronto and Vancouver. For more information, please visit http://www.mindray.com .


'/>"/>
SOURCE Mindray Medical International Limited
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Mindray Announces 2008 Third Quarter and Nine Months Results
2. Mindray to Report Third Quarter 2008 Financial Results on November 11, 2008
3. Mindray Medical to Exhibit New Products at 60th China International Medical Equipment Fair
4. Mindray Releases Historical Financial Results Converted into US Dollar Terms
5. Mindray to Unveil Three New Products and Reagents at AACC Annual Meeting
6. Mindray Announces 20-F Filing
7. Mindrays AS3000(TM) Anesthesia Delivery System Receives U.S. FDA Clearance
8. Mindrays DC-3 Color Ultrasound Gains U.S. FDA 510(k) Clearance
9. Mindray to Attend Morgan Stanley China Summit 2008
10. Mindray Donates Cash and Equipment for Sichuan Earthquake Relief
11. Mindray to Attend Goldman Sachs 29th Annual Global Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... June 27, 2016 , ... ... authorized OSHA Training Institute Education Center headquartered in Northern California, has issued an ... extreme heat at their worksites. Employers with workers exposed to high temperatures ...
(Date:6/27/2016)... ... June 27, 2016 , ... "FCPX editors can now reveal ... Final Cut Pro X," said Christina Austin - CEO of Pixel Film Studios. ... Cut Pro X users can now reveal the media of their split screens ...
(Date:6/27/2016)... ... ... TherapySites, the leading website and online marketing ... Association. This new relationship allows TherapySites to continue to extend their online ... and promotional offers. , "TCA is extremely excited about this new partnership, as ...
(Date:6/27/2016)... ... June 27, 2016 , ... ... its strategic partnership with Connance, a healthcare industry leader providing predictive analytics ... proprietary technology combine to provide health systems, hospitals and ambulatory surgical centers ...
(Date:6/27/2016)... ... June 27, 2016 , ... ... to revolutionize the emergency ambulance transport experience for the millions of people who ... Uber has disrupted the taxi industry through the use of technology. Now, SmartEMS ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... Australia,s successful biotechnology scientists, Dr Graham ... Noxopharm Limited [ABN 50 608 966 123] ("Noxopharm"). Noxopharm is seeking ... ASX. Noxopharm is a clinic-ready company with its first ... study later this year. NOX66 ... cancer patients - the ability of cancers to become resistant to ...
(Date:6/26/2016)... Jazz Pharmaceuticals plc (Nasdaq: JAZZ ) announced ... Act of 1976, as amended ("HSR"), with respect to ... CPXX ) expired effective June 24, 2016, ... previously announced on May 31, 2016, Jazz Pharmaceuticals and ... Jazz Pharmaceuticals has commenced a tender offer for all ...
(Date:6/26/2016)... Ontario , June 27, 2016  VMS Rehab ... Company,s Board will take whatever measures required to build ... Company,s stock which is currently listed on the OTC ... Wexler, Company Chairman and CEO, "We are seeing an ... difficult to understand, not only by the Company, but ...
Breaking Medicine Technology: